Find Ilunocitinib manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 1187594-14-4, Ilunocitinib [usan], Ly3411067, N3tb5ah8b9, Ly-3411067, 2-[1-cyclopropylsulfonyl-3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetonitrile
Molecular Formula
C17H17N7O2S
Molecular Weight
383.4  g/mol
InChI Key
RVOUEXFKIYNODQ-UHFFFAOYSA-N
FDA UNII
N3TB5AH8B9

Ilunocitinib
1 2D Structure

Ilunocitinib

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[1-cyclopropylsulfonyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetonitrile
2.1.2 InChI
InChI=1S/C17H17N7O2S/c18-5-4-17(9-23(10-17)27(25,26)13-1-2-13)24-8-12(7-22-24)15-14-3-6-19-16(14)21-11-20-15/h3,6-8,11,13H,1-2,4,9-10H2,(H,19,20,21)
2.1.3 InChI Key
RVOUEXFKIYNODQ-UHFFFAOYSA-N
2.2 Other Identifiers
2.2.1 UNII
N3TB5AH8B9
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 1187594-14-4

2. Ilunocitinib [usan]

3. Ly3411067

4. N3tb5ah8b9

5. Ly-3411067

6. 2-[1-cyclopropylsulfonyl-3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetonitrile

7. Ilunocitinib [inn]

8. 3-azetidineacetonitrile, 1-(cyclopropylsulfonyl)-3-(4-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)-1h-pyrazol-1-yl)-

9. 1-(cyclopropylsulfonyl)-3-(4-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-azetidineacetonitrile

10. 2-(1-cyclopropylsulfonyl-3-(4-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)pyrazol-1-yl)azetidin-3-yl)acetonitrile

11. Refchem:147900

12. Unii-n3tb5ah8b9

13. Who 11894

14. (1-(cyclopropanesulfonyl)-3-(4-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)-1h-pyrazol-1-yl)azetidin-3-yl)acetonitrile

15. 2-(3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-1-(cyclopropylsulfonyl)azetidin-3-yl)acetonitrile

16. Schembl870650

17. Orb2704076

18. Orb2944228

19. Chembl4802241

20. Schembl29577031

21. Gtpl11670

22. Rvouexfkiynodq-uhfffaoysa-n

23. Ex-a9647

24. Akos040756527

25. Da-74442

26. Ms-26294

27. Hy-132819

28. Cs-0204093

29. G18507

30. (1-(cyclopropylsulfonyl)-3-(4-(1,5,7-triaza-1h-inden-4-yl)-1-pyrazolyl)-3-azetidinyl)acetonitrile

2.4 Create Date
2009-10-19
3 Chemical and Physical Properties
Molecular Weight 383.4 g/mol
Molecular Formula C17H17N7O2S
XLogP3-0.3
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count7
Rotatable Bond Count5
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area129
Heavy Atom Count27
Formal Charge0
Complexity734
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

API SUPPLIERS

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty